Contribución de los invitados: en el mercado criptográfico actual, XRP se ha convertido en el protagonista absoluto. Si... The post Aumento del USD: Las entradas de ETF de XRP explotan a medida que los tenedores agotan las reservas cambiarias apareció por primera vez en Sala de prensa Panamá.
La realidad se está desvaneciendo ante nuestros ojos. La suplantación de identidad solo contra adultos mayores se multiplicó por 8 entre 2020 y 2024, impulsada en parte por suplantaciones convincentes de amigos y seres queridos por parte de la IA. Es un problema que le cuesta a la gente en Estados Unidos casi 500 millones de dólares al año y no tiene fin a la vista. Es por eso que un par de estudios de diseño se unieron para crear una solución provocativa que comienza con un apretón de manos en la vida real. Llamado Quartz, es un anillo que agrega amigos a su red literalmente estrechando manos. Y a partir de ahí, controla sus comunicaciones en línea demostrando que está vivo, que conoce a la persona con la que está hablando y que demuestra su procedencia a través de canales cifrados. Si alguna de estas comprobaciones falla, todo, desde mensajes de texto hasta mensajes directos de Instagram, se cortará para evitar la suplantación de identidad. El proyecto especulativo fue desarrollado por los estudios de diseño Modem y Retinaa. Pero si bien es puramente un concepto, las ideas ofrecen una especie de modelo que parece factible para la producción. [Fotos: Quartz]Cómo funciona QuartzTodo comienza con un anillo, encajado con un trozo de cuarzo. Ese cuarzo es exclusivo de su anillo, con geometrías que se transponen directamente a un certificado blockchain vinculado a su joyería específica. El anillo también está cargado con un escáner de venas, que puede ver debajo de la piel para medir sus vasos sanguíneos únicos. Este escaneo se convierte en una imagen verificable de usted, similar a FaceID. Mientras tanto, la medición integrada del pulso garantiza que usted esté en condiciones de vivir y respirar cada vez que se verifique su identidad. Cuando conoce a alguien por primera vez, le da la mano y, a través de NFC, su anillo y el de él generan una clave criptográfica "secreta compartida". Esa clave se convierte en la base de todas sus comunicaciones futuras. Si alguna pieza falla, los canales de comunicación se apagan. Naturalmente, toda esta fricción limita la cantidad de personas que podrían estar en su propia red Quartz, lo que reintroduce barreras físicas a la amistad que han sido más o menos borradas en el mundo moderno. En última instancia, no todos los amigos de tu página de Instagram o TikTok podrían formar parte de esta red. Pero eso es también lo que te permite proteger tan estrechamente tus relaciones más preciadas. [Foto: Quartz] ¿Distopía o utopía? Ahora, todavía hay algo. . . ¿hacia atrás? . . ¿misterioso? . . ¿deprimente? sobre el uso de una serie de tecnologías digitales para verificar nuestras relaciones en la vida real. Pero esa paradoja es intencionada, según Scott Kooken, director de investigación y diseño de Modem. "Mientras que la mayoría de los sistemas de identidad en línea se construyen a partir de matemáticas abstractas y flujos de datos invisibles, Quartz reintroduce algo físico y humano", escribe por correo electrónico. "La presencia física es una capa fundamental del conjunto de seguridad. Sin ella, el sistema se desmorona. En un mundo donde todo lo demás se puede sintetizar, eso es precisamente lo que la convierte en la capa más valiosa de todas. El apretón de manos no es simbólico: es parte de la arquitectura". De hecho, con Quartz, la seguridad es el diseño, que es la cultura; su seguridad se basa en un ritual humano que gestiona tanto la UX natural del anillo como su capa criptográfica invisible. Para ver lo que quiero decir con esto, compare Quartz con el escáner de globo ocular del tamaño de una pelota de voleibol propuesto por Tools for Humanity de Sam Altman. Este objeto tiene en gran medida la misma función que Quartz: escanear los datos biométricos de alguien para demostrar que es quien dice ser. Pero este escáner ocular está completamente divorciado de los rituales y las relaciones interpersonales del mundo real; toda la idea parece sacada de una película de James Cameron de la década de 1990, o quizás de una cámara web Logitech de mediados de los años. En este momento, con la IA destruyendo más o menos todo lo relacionado con nuestras vidas digitales, tenemos la más estrecha de las ventanas para reimaginar lo que hicimos mal en nuestro primer intento por Internet y las tecnologías móviles. Podemos decidir si queremos vivir en una sociedad llena de apretones de manos o escaneos de iris. ¿Pero lo haremos? Ja ja. No. Probablemente no lo haremos. Simplemente conecte TikTok a mi marcapasos y déjelo listo.
Descubra las implicaciones de la multa de 358,75 millones de rands de la FSCA al ex ejecutivo de Steinhoff, Stehan Grobler, mientras Sudáfrica lidia con las consecuencias de uno de sus mayores escándalos corporativos.
La mayoría de los inversores prevén otro año de rentabilidad positiva en 2026, y casi nadie espera una corrección.
Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 48.2% to $27.9 million in the fourth quarter of 2025 from $18.9 million in the fourth quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $87.7 million in the fourth quarter of 2025 as compared with $75.0 million in the fourth quarter of 2024, an increase of 16.9%; Digital Health reportable segment Adjusted EBITDA(1) increased 8.9% to $4.9 million in the fourth quarter of 2025 from $4.5 million in the fourth quarter of 2024Total Company Adjusted EBITDA(1) margins increased by 29 bps to 16.0% in the fourth quarter of 2025 as compared with 15.7% in the fourth quarter of 2024Adjusting for unusual or one-time items impacting Net Income in the quarter, Adjusted Earnings Per Share(3) was $0.23 for the fourth quarter of 2025; This compares with Adjusted Earnings Per Share(3) of $0.24 for the fourth quarter of 2024 In the fourth quarter of 2025, aggregate advanced imaging (MRI, CT and PET/CT) procedural volumes increased 14.1% and same-center advanced imaging procedural volumes increased 9.6% as compared with the fourth quarter of 2024RadNet releases 2026 guidance levels which anticipate Imaging Center segment Revenue growth of 17%-19%, Adjusted EBITDA(1) growth of 18%-22% and Free Cash Flow(2) growth of 29%-41% from 2025 levels; 2026 guidance levels anticipate Digital Health Revenue growth of 46%-56%LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 418 owned and/or operated outpatient imaging centers, today reported financial results for its fourth quarter and full-year ended December 31, 2025.Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, "I am very pleased with the fourth quarter performance. Relative to last year's fourth quarter, Total Company Revenue increased 14.8% and Adjusted EBITDA(1) increased 16.9%, resulting in margin improvement of 29 basis points. This performance was driven by strong aggregate and same center procedural growth, combined with a continued focus on driving operating and clinical efficiencies within the Imaging Center segment. These factors, amongst others, contributed to RadNet exceeding 2025 Revenue and Adjusted EBITDA(1) guidance levels in the Imaging Center segment, which had been amended upwards throughout the year."Dr. Berger continued, "During the fourth quarter, we continued to experience increasing demand for our services in virtually all core markets, and operations teams were focused on improving patient-throughput and driving capacity at existing centers. In particular, disproportionately higher demand for advanced imaging continues to benefit our procedure mix, evidenced by a 178 basis point increase in MR, CT and PET/CT as a percentage of our overall procedure volume when compared with the fourth quarter of last year. At the same time, during the fourth quarter and throughout 2025, significant investments were made to open new centers and complete tuck-in acquisitions within virtually all core RadNet markets. RadNet centers continue to implement DeepHealth technology solutions to drive efficiencies, lower costs and automate manual processes. This includes the comprehensive roll-out of TechliveTM, See-Mode and other clinical and workflow tools designed to increase productivity, create capacity and decrease exposure to the challenging labor market. In the coming quarters, as we continue to implement many of these solutions internally, we will have the opportunity to demonstrate the power of improved automation and more advanced clinical and operational capabilities, which we believe will lead to more favorable patient care and health outcomes, improved service levels to referring physicians, further alignment with health system partners and closer relationships with insurance plans and other payors.""Moving into 2026, RadNet is well-positioned to accelerate growth within Digital Health. With the addition of products resulting from this morning's acquisition of Gleamer in Paris, France, the Digital Health division now includes what we believe to be the most comprehensive and broad collection of clinical AI solutions of any company worldwide. This will have broad implications for the performance of RadNet's core Imaging Center business, the businesses of the over 2,700 current Digital Health customers and future customers throughout the diagnostic imaging industry. The diagnostic imaging industry will transform in the coming years as a result of an industry-wide adoption of the kind of AI-powered workflow and clinical tools that RadNet is acquiring, developing, utilizing and commercializing. We intend to continue to develop and bring-to-market solutions that address the critical challenges the industry faces, including labor shortages, capacity constraints and the inability of radiologists to keep pace with growing industry volumes, all in an effort to improve patient care and outcomes," concluded Dr. Berger.Financial ResultsFourth Quarter Report:For the fourth quarter of 2025, RadNet reported Total Company Revenue of $547.7 million and Adjusted EBITDA(1) of $87.7 million. Revenue increased $70.6 million (or 14.8%) and Adjusted EBITDA(1) increased $12.7 million (or 16.9%) as compared with the fourth quarter of 2024. For the fourth quarter of 2025, RadNet reported Digital Health Revenue of $27.9 million (inclusive of intersegment revenue) and Adjusted EBITDA(1) of $4.9 million. Revenue increased $9.1 million (or 48.2%) and Adjusted EBITDA(1) increased $0.4 million (or 8.9%) as compared with the fourth quarter of 2024.There were a number of unusual or one-time items impacting the fourth quarter including: $531,000 in severance expense related to cost-savings initiatives; $233,000 impairment loss on lease abandonment; $788,000 expense related to leases for de novo facilities under construction that have yet to open their operations; $2.3 million of acquisition transaction costs; $6.5 million loss on sale and disposal of equipment; $6.3 million of non-capitalized research and development expenses related to the DeepHealth products; $679,000 of non-cash loss from interest rate swaps; and $5.7 million adjustment to the tax provision to normalize nonrecurring and prior year tax adjustments. Adjusting for the above items, Total Company Adjusted Earnings(3) was $18.1 million and diluted Adjusted Earnings Per Share(3) was $0.23 during the fourth quarter of 2025. This compares with Total Company Adjusted Earnings(3) of $18.1 million and diluted Adjusted Earnings Per Share(3) of $0.24 during the fourth quarter of 2024.Unadjusted for unusual or one-time items impacting the fourth quarter, Total Company Net Loss for the fourth quarter of 2025 was $0.6 million as compared with a Total Company Net Income of $5.3 million for the fourth quarter of 2024. Fully diluted Net Loss Per Share for the fourth quarter of 2025 was $(0.01), compared with a fully diluted Net Income per share of $0.07 in the fourth quarter of 2024, based upon a weighted average number of diluted shares outstanding of 76.6 million shares in 2025 and 75.5 million shares in 2024.For the fourth quarter of 2025, as compared with the prior year's fourth quarter, MRI volume increased 15.8%, CT volume increased 10.3% and PET/CT volume increased 28.3%. Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 7.0% over the prior year's fourth quarter. On a same-center basis, including only those centers which were part of RadNet for both the fourth quarters of 2025 and 2024, MRI volume increased 11.4%, CT volume increased 6.3% and PET/CT volume increased 14.3%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 4.5% over the prior year's same quarter.Annual Report:For full-year 2025, RadNet reported Total Company Revenue of $2,040.2 million and Adjusted EBITDA(1) of $300.2 million. Revenue increased $210.5 million (or 11.5%) and Adjusted EBITDA(1) increased $20.8 million (or 7.4%) as compared with full-year 2024. For full-year 2025, RadNet reported Digital Health Revenue (inclusive of intersegment revenue) of $92.7 million and Adjusted EBITDA(1) of $15.5 million. Revenue increased $27.0 million (or 41.1%) and Adjusted EBITDA(1) increased $0.3 million (or 1.9%) as compared with full-year 2024. At December 31, 2025, Annual Recurring Revenue(4) (ARR) for the Digital Health was $75.4 million, representing 81.3% of 2025 Revenue.Unadjusted for one-time or unusual items, Total Company Net Loss for 2025 was $18.7 million as compared with a Total Company Net Income of $2.8 million in 2024. Fully diluted Net Loss Per Share for 2025 was $(0.25), compared with a Net Income per share of $0.04 in 2024, based upon a weighted average number of diluted shares outstanding of 75.2 million shares in 2025 and 74.8 million shares in 2024.Actual 2025 Results vs. 2025 GuidanceImaging Center Segment Original Guidance Range Revised Guidance Range After Q1 Results Revised Guidance Range After Q2 Results Revised Guidance Range After Q3 Results Actual 2025 Results Total Net Revenue$1,825-$1,875mm $1,835-$1,885mm $1,850-$1,900mm $1,900-$1,930mm $1,988.2mmAdjusted EBITDA(1)$265 - $273mm $268 - $276mm $271 - $279mm $276 - $284mm $284.7mmCapital Expenditures(a)$140 - $150mm $145 - $155mm $152 - $162mm $157 - $167mm $170.5mmCash Interest Expense(b)$35 - $40mm $35 - $40mm $35 - $40mm $31 - $36mm $32.5mmFree Cash Flow (2)$70 - $80mm $70 - $80mm $70 - $80mm $70 - $80mm $81.7mm (a) Net of proceeds from the sale of equipment and New Jersey Imaging Network capital expenditures.(b) Net of payments received from counterparties on interest rate swaps and interest income from our cash balance recorded in Other Income.Digital Health Segment Original Guidance Range Revised Guidance Range After Q2 Results Revised Guidance Range After Q3 Results Actual 2024 Results Total Net Revenue (inclusive of intersegment revenue)$80 - $90mm $80 - $90mm $85 - $95mm $92.7mm Adjusted EBITDA(1) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$15 - $17mm $15 - $17mm $15 - $17mm $15.5mm Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$16 - $18mm $17 - $19mm $18 - $20mm $20.2mm Capital Expenditures(a)$3 - $5mm $2 - $4mm $3 - $5mm $2.0mm Free Cash Flow(2) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$11 - $13mm $11 - $13mm $10 - $12mm $13.5mm Free Cash Flow(2) After Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$(5) - $(8)mm $(5) - $(8)mm $(5) - $(9)mm $(6.7)mm (a) Excludes a $2.6 million purchase of software code and other intellectual property.2026 GuidanceRadNet reports 2026 guidance ranges as follows: Imaging Center Segment 2026Guidance Range Total Net Revenue$2,325 - $2,375Adjusted EBITDA(1)$335 - $348 millionCapital Expenditures(a)$165 - $175 millionCash Interest Expense(b)$45 - $50 millionFree Cash Flow(2)$105 - $115 million (a) Net of proceeds from the sale of equipment and New Jersey Imaging Network capital expenditures.(b) Net of payments from counterparties on interest rate swaps and interest income earned from our cash balance recorded in Other Income.Dr Berger added, "Within the Imaging Center segment, we expect 2026 performance to benefit from the contribution of continued increases in same-center performance, further tuck-in acquisitions, reimbursement efforts driving more favorable pricing and de novo center openings. As a result, our guidance implies 2026 Revenue to grow 17%-19%, Adjusted EBITDA(1) to grow 18%-22% and Free Cash Flow(2) to grow 29%-41% as compared with 2025 full year performance. We are anticipating this strong growth despite headwinds embedded in the guidance levels from projected increases in same-center labor costs as well as the recent impact of severe winter weather conditions experienced in January and February."Digital Health Segment 2026Guidance Range Total Net Revenue(a)$135 - $145 million Adjusted EBITDA(1) Before Non-Capitalized R&D(b)$10 - $12 million Non-Capitalized R&D$17 - $19 million Capital Expenditures$9 - $12 million Free Cash Flow(2) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$(1) - $3 million Free Cash Flow(2) After Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$(17) - $(19) million (a) Includes approximately $16 million of Revenue as a result of the acquisition of Gleamer SAS announced this morning.(b) Includes a loss of approximately $5 million of Adjusted EBITDA(1) Before Non-Capitalized R&D as a result of the acquisition of Gleamer SAS announced this morning."Within the Digital Health segment, 2026 growth will be driven by sales of the DeepHealth portfolio of AI-powered workflow and clinical solutions and related products such as TechLiveTM and further contribution from the acquisitions of iCAD, See-Mode, CIMAR and Gleamer. We are anticipating a minimum of four FDA clearances during 2026, further advancing our leadership in radiology clinical AI solutions in the areas of mammography, lung, prostate, thyroid, brain and, with this morning's announced acquisition of Gleamer, the musculoskeletal system. In 2026, significant infrastructure investments will continue to be made in building sales, marketing and implementation teams to support future growth. Despite the continued focus it takes to invest in building the infrastructure of the business, 2026 Digital Health guidance implies growth of Revenue between 45% and 55% from 2025 full-year performance. We anticipate ARR at December 31, 2026 to approach or exceed $140 million. Furthermore, we expect that the proportion of Digital Health's Revenue coming from RadNet's Imaging Center segment will decline from approximately 45% in 2025 to about 33% in 2026," concluded Dr. Berger.Conference Call TodayDr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call today, March 2nd, at 10:30 a.m. Eastern Time. During the call, management will discuss the Company's 2025 fourth quarter and year-end results.Conference Call Details:Date: Monday, March 2, 2026Time: 10:30 a.m. ETDial In-Number: 844-826-3035International Dial-In Number: 412-317-5195There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1753363&tp_key=503d78aa96 [viavid.webcasts.com] or http://www.radnet.com under the "About RadNet" menu section and "News & Press Releases" sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10206844.About RadNet, Inc.RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet's markets include Arizona, California, Delaware, Florida, Indiana, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. Learn more at www.radnet.com.Forward Looking StatementsThis press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. Forward-looking statements in this press release include statements about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to service or refinance our current indebtedness.Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:changes in general economic conditions nationally and regionally in the markets in which we operate, including their effects on the cost and availability of labor;our ability to service our indebtedness, make principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition to our ability to refinance such indebtedness on acceptable terms;the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities;our ability to maintain our current credit rating and the impact on our funding costs and competitive position if we do not do so;volatility in interest and exchange rates, or credit markets;the adequacy of our cash flow and earnings to fund our current and future operations;changes in service mix, revenue mix and procedure volumes;delays in receiving payments for services provided;increased bankruptcies among our partner physicians or joint venture partners;the impact of the political environment and related developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act;the extent to which the ongoing implementation of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators or related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our business;closures or slowdowns and changes in labor costs and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies needed in our facilities;the occurrence of hostilities, political instability or catastrophic events;the emergence or reemergence of and effects related to future pandemics, epidemics and infectious diseases; andnoncompliance by us with any privacy or security laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss or other unauthorized use or disclosure of confidential information.Any forward-looking statement contained in this current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.Regulation G: GAAP and Non-GAAP Financial InformationThis release contains certain financial information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this release in the tables which follow.CONTACTS: RadNet, Inc.Mark Stolper, 310-445-2800Executive Vice President and Chief Financial Officer RADNET, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA) December 31, 2025 December 31, 2024 ASSETS CURRENT ASSETS Cash and Cash equivalents$767,215 $740,020 Accounts receivable 200,317 185,821 Due from affiliates 12,592 41,869 Prepaid expenses and other current assets 52,003 51,542 Total current assets 1,032,127 1,019,252 PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS Property and equipment, net 807,702 694,791 Operating lease right-of-use assets 690,250 639,740 Total property, plant, equipment and right-of-use assets 1,497,952 1,334,531 OTHER ASSETS Goodwill 907,663 710,663 Other intangible assets 148,508 81,351 Deferred financing costs 1,684 2,265 Investment in joint ventures 130,340 104,057 Deposits and other 40,289 34,571 Total Assets$3,758,563 $3,286,690 LIABILITIES AND EQUITY CURRENT LIABILITIES Accounts payable, accrued expenses and other$422,029 $351,464 Due to affiliates 70,104 43,650 Deferred revenue 7,272 3,288 Current operating lease liability 61,934 56,618 Current portion of notes payable 25,424 24,692 Total current liabilities 586,763 479,712 LONG-TERM LIABILITIES Long-term operating lease liability 707,001 655,979 Notes payable, net of current portion 1,064,495 991,574 Deferred tax liability, net 21,903 22,230 Other non-current liabilities 22,515 3,785 Total liabilities 2,402,677 2,153,280 EQUITY RadNet, Inc. stockholders' equity: Common stock - $0.0001 value, 200,000,000 shares authorized; 77,399,615 and 74,036,993 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively 8 7 Additional paid-in-capital 1,180,434 988,147 Accumulated other comprehensive loss 4,885 (9,061)Accumulated deficit (95,437) (76,785)Total RadNet, Inc.'s Stockholders' equity: 1,089,890 902,308 Noncontrolling interests 265,996 231,102 Total Equity 1,355,886 1,133,410 Total liabilities and equity$3,758,563 $3,286,690 RADNET, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENT OF OPERATIONS(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA) Years Ended December 31, 2025 2024 2023 REVENUE Service fee revenue$1,914,673 $1,693,089 $1,463,197 Revenue under capitation arrangements 125,537 136,575 153,433 Total service revenue 2,040,210 1,829,664 1,616,630 OPERATING EXPENSES Cost of operations, excluding depreciation and amortization 1,804,725 1,580,549 1,395,239 Lease abandonment charges 8,563 2,478 5,146 Depreciation and amortization 152,127 137,838 128,391 Loss ...Full story available on Benzinga.com
VANCOUVER, Columbia Británica, 02 de marzo de 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), una empresa de biotecnología que administra una cartera de activos de atención médica con licencia, mientras desarrolla una cartera diversa de bioterapéuticos novedosos y multifuncionales, informó hoy los resultados financieros para el cuarto trimestre y el año finalizado el 31 de diciembre de 2025 y proporcionó un resumen de los aspectos más destacados del negocio reciente.
TORONTO, 02 de marzo de 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay”) (TSX, NYSE: HBM) y Arizona Sonoran Copper Company Inc. (“ASCU”) (TSX: ASCU; OTCQX: ASCUF) se complacen en anunciar que han celebrado un acuerdo definitivo (el “Acuerdo de Arreglo”) según el cual Hudbay acordó adquirir todas las acciones ordinarias emitidas y en circulación de ASCU, que aún no es propiedad de Hudbay, por la contraprestación de 0,242 de una acción ordinaria de Hudbay por acción ordinaria de ASCU (la “Transacción”). La oferta implica un valor de C$9,35 por acción de ASCU según el precio de cierre de las acciones de Hudbay en la Bolsa de Valores de Toronto (“TSX”) el 27 de febrero de 2026, y representa una prima del 30 % sobre el precio de cierre de las acciones de ASCU el 27 de febrero de 2026. La oferta implica una prima del 36 % según los precios promedio ponderados por volumen de 20 días de las acciones de Hudbay y ASCU ("VWAP") en la TSX para el período que finaliza el 27 de febrero de 2026. La transacción dará como resultado que Hudbay posea una participación del 100% en el proyecto Cactus de ASCU ("Cactus").
TORONTO, 02 de marzo de 2026 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) ("Discovery" o la "Compañía") se complace en anunciar que ha celebrado un acuerdo definitivo (el "Acuerdo") para adquirir, a través de una subsidiaria de propiedad total, la participación del 100% de Glencore Canada Corporation ("Glencore") en las operaciones de Kidd ("Kidd" o “Operaciones Kidd”) en Timmins, Ontario (la “Transacción”). Las Operaciones Kidd incluyen el Sitio Metalúrgico Kidd (el “Sitio Kidd Met”), el área de manejo de relaves Kidd (el “Kidd TMA” o el “TMA”) y la mina de cobre, zinc y plata Kidd Creek (la “Mina Kidd Creek”). Todos los montos están en dólares estadounidenses a menos que se especifique lo contrario.
El aumento de los precios del petróleo, el debilitamiento del rand y los riesgos de inflación podrían afectar la frágil recuperación de Sudáfrica.
K92 anuncia resultados financieros para 2025: saldo de efectivo neto, ingresos, ganancias netas, flujo de efectivo y EBIDTA, producción, costos de efectivo récord, AISC por debajo de la guía
/NO PARA DISTRIBUCIÓN A SERVICIOS DE NEWSWIRE DE EE. UU. O PARA LANZAMIENTO, PUBLICACIÓN, DISTRIBUCIÓN O DIFUSIÓN DIRECTA O INDIRECTA, TOTAL O PARCIALMENTE, EN O EN LOS ESTADOS UNIDOS/TORONTO, 2 de marzo de 2026 /CNW/ - Arizona Metals Corp. (TSX:AMC) (OTCQX:AZMCF) (la "Compañía" o "Arizona Metals") se complace en anunciar la tercera y última ronda de resultados de su programa de perforación de circulación inversa de 2025 en el Proyecto de Oro Sugarloaf Peak de la Compañía (el "Proyecto Sugarloaf Peak") en Arizona, que arrojó la ley de oro más alta en el proyecto hasta la fecha. De acuerdo con los resultados anteriores del programa de perforación 2025 de la Compañía, estos resultados finales de perforación amplían el depósito y confirman una excelente continuidad de la mineralización dentro de un depósito de oro cada vez más grande. Los aspectos más destacados de la perforación incluyen:SP-25-28: 91,4 m @ 0,69 g/t Au, incluidos 1,5 m @ 25,5 g/t Au, la ley de oro más alta en la propiedad hasta la fecha (incluidas muestras de superficie). Este pozo, junto con el pozo 29, extendió la mineralización aproximadamente 80 m hacia el sur en un área previamente no perforada (Figura 1). El pozo 28 también cruzó 57,9 m @ 0,29 g/t Au y 18,3 m @ 0,39 g/t Au (Tabla 1). SP-25-29: 123,4 m @ 0,31 g/t Au. Este agujero intersectó un gran espesor de mineralización que comenzaba en la superficie en un área no probada previamente en el margen sur del depósito. Los pozos 29 y 28 (con collar en el mismo lugar) muestran un potencial excepcional para la expansión continua del depósito lateralmente hacia el sur/suroeste y a lo largo del rumbo hacia el sureste. SP-25-26: 56,4 m @ 0,43 g/t Au. El hoyo 26 probó una brecha de 270 x 340 m en el extremo oriental del depósito e intersectó una mineralización espesa, reforzando la excelente continuidad de la mineralización en Sugarloaf Peak. Los seis hoyos de perforación finales cruzaron la mineralización, haciendo crecer el depósito lateralmente y reforzando la fuerte continuidad de la mineralización en el proyecto. La perforación total hasta la fecha en el proyecto, en 2025 y 2026, comprende 5.186 m perforados en 25 barrenos de circulación inversa. Duncan Middlemiss, presidente y director ejecutivo de Arizona Metals, comentó: "Estamos muy alentados con estos resultados de nuestro programa de perforación de 2025 en Sugarloaf Peak. Esta ha sido la campaña de perforación más exitosa en el proyecto hasta la fecha, cruzando mineralización en 22 de 25 barrenos y mostrando una expansión significativa. ventajas y excelente continuidad de un depósito de oro que ya es grande y que aflora en la superficie. La perforación de la Compañía muestra que Sugarloaf es un depósito de oro sólido y esperamos seguir desarrollando su valor. Los resultados de perforación adicionales son los siguientes: SP-25-24: 24,4 m @ 0,23 g/t Au y 30,5 m @ 0,32 g/t Au. Este es un pozo de relleno en un espacio de 225 x 475 m en la parte noroeste del depósito. SP-25-27: 51,8 m @ 0,30 g/t Au y 27,4 m @ 0,34 g/t Au. El hoyo 27 intersectó mineralización espesa en un espacio de 340 x 360 m en el extremo oriental del depósito. Actualmente, la Compañía está llevando a cabo una síntesis de exploración integral que consta de 990 muestras de roca superficial para geoquímica de elementos múltiples; geofísica de resistividad IP y geofísica magnética y radiométrica aérea; un estudio hiperespectral aéreo; revisiones geológicas de mapeos previos, núcleos de perforación y cortes de perforación; estudios de focalización de IA; y una integración exhaustiva de datos históricos. La intención de este programa de exploración es integrar nuevos datos geoquímicos, geofísicos y geológicos modernos con datos históricos para apuntar de manera integral a la perforación para lograr un tamaño de depósito ampliado y leyes de oro más altas. Tabla 1. Resultados del programa de perforación en el Proyecto Sugarloaf Peak, condado de La Paz, Arizona, anunciados en este comunicado de prensa, incluida la profundidad de la mineralización oxidada encontrada en cada pozo. El verdadero ancho de la mineralización no se ha determinado en este momento. La historia completa está disponible en Benzinga.com
A medida que aumentan los temores de un desempleo masivo, tres destacados economistas abogan por algunas políticas para cambiar el enfoque del desplazamiento de empleos a la mejora del empleo.